Day: April 30, 2024

SHANGHAI, China, April 29, 2024 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it has filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) on April 29, 2024, U.S. Eastern Time. The Annual Report can be accessed on the Company’s investor relations website at https://ir.jiayintech.cn/ and on the SEC’s website at https://www.sec.gov/. The Company will provide a hard copy of its Annual Report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at...

VANCOUVER, British Columbia, April 29, 2024 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or “the Company”) announces that it has approved the grant of 22,348 DSUs having an aggregate value of $40,000 to independent directors of the Company pursuant to the Company’s Omnibus Long-Term Incentive Plan, which was approved by the Company’s shareholders at its last shareholder meeting. About Osino Resources Corp. Osino is a Canadian gold exploration and development company focused on the fast-tracked development of our wholly owned, Twin Hills Gold Project in central Namibia. Since its grassroots discovery by Osino in August 2019 the Company has completed more than 250,000m of drilling and has completed a suite of specialist technical studies culminating in the recently published Twin Hills...

Announces Another Double-Digit Growth and Record Year of 2023 Results with Material Progress on Strategic Reorganization Reported figures all in U.S. Dollars Boston, MA, April 29, 2024 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 52 weeks ended December 31, 2023 (“FY2023”). The fiscal year of MiniLuxe is a 52-week reporting cycle ending on the Sunday closest to December 31, which periodically necessitates a fiscal year of 53 weeks. FY2022 consisted of a 53-week period while all other fiscal years referred to in this release consist of 52-week periods. Unless otherwise specified, all amounts are reported in U.S. dollars. MiniLuxe is pleased to announce strong, organic, year-over-year growth as FY2023 revenue increased 14% over FY2022 (17% when compared on a like-for-like 52-week...

2023 Adjusted Revenue1 record revenue of $17.05 million, an increase of 102% compared to 2022. 2023 GAAP revenue was $11.51 million an increase of 170% compared to 2022. 2023 gross margin of 43.11% compared to 43.00% in 2022. Q4, 2023 Adjusted Revenue1 of $4.99 million, an increase of 77% compared to Q4, 2022. Q4, 2023 GAAP revenue was $3.37 million an increase of 99% compared to Q4, 2022. Q4, 2023 gross margin of 46.54% compared to 43.77% in Q4, 2022 Expanded service offering to over 700 cities across 50 states in the United States. Named one of Canada’s Companies to Watch as part of the 2023 Deloitte Technology Fast 50™ program The Company has approximately 107 white-label locations nationwide, with new locations opening every month.  Hydreight Added Semaglutide to Product Offerings in Dec 2023 The Company onboarded 2,249...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 29, 2024 (GLOBE NEWSWIRE) — Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost Lithium”, “Foremost” or the “Company”), a North American hard-rock lithium exploration company, announces that further to its press releases dated February 13, 2024 and March 13, 2024, on April 29, 2024, it closed the second tranche of its non-brokered private placement (the “Offering“) for aggregate gross proceeds of $1,455,129.48 pursuant to an arrangement with Wealth Creation Preservation & Donation Inc. (“WCPD”). Foremost issued 247,471 flow-through units (each, a “FT Unit”) at a subscription price of $5.88 per FT Unit, comprised of one flow-through common share in the...

WORCESTER, Mass., April 29, 2024 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced the pricing of a public offering of an aggregate of 16,877,638 shares of its common stock (or common stock equivalents in lieu thereof), Series A-1 warrants to purchase up to 16,877,638 shares of common stock, Series A-2 warrants to purchase up to 16,877,638 shares of common stock and Series A-3 warrants to purchase up to 16,877,638 shares of common stock, at a combined public offering price of $0.237 per share (or per common stock equivalent in lieu thereof) and accompanying warrants. The warrants will...